{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,27]],"date-time":"2026-10-27T16:47:36Z","timestamp":1793119656347,"version":"4.5.0"},"reference-count":51,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2024,11,1]],"date-time":"2024-11-01T00:00:00Z","timestamp":1730419200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,11,1]],"date-time":"2024-11-01T00:00:00Z","timestamp":1730419200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2024,9,18]],"date-time":"2024-09-18T00:00:00Z","timestamp":1726617600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/100000049","name":"National Institute on Aging","doi-asserted-by":"publisher","award":["R01AG084236"],"award-info":[{"award-number":["R01AG084236"]}],"id":[{"id":"10.13039\/100000049","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000049","name":"National Institute on Aging","doi-asserted-by":"publisher","award":["R01AG083039"],"award-info":[{"award-number":["R01AG083039"]}],"id":[{"id":"10.13039\/100000049","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000049","name":"National Institute on Aging","doi-asserted-by":"publisher","award":["RF1AG072799"],"award-info":[{"award-number":["RF1AG072799"]}],"id":[{"id":"10.13039\/100000049","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000049","name":"National Institute on Aging","doi-asserted-by":"publisher","award":["R56AG074604"],"award-info":[{"award-number":["R56AG074604"]}],"id":[{"id":"10.13039\/100000049","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["thelancet.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["eBioMedicine"],"published-print":{"date-parts":[[2024,11]]},"DOI":"10.1016\/j.ebiom.2024.105378","type":"journal-article","created":{"date-parts":[[2024,10,3]],"date-time":"2024-10-03T15:37:03Z","timestamp":1727969823000},"page":"105378","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":21,"special_numbering":"C","title":["Association between risk of Alzheimer\u2019s disease and related dementias and angiotensin receptor \u2161 blockers treatment for individuals with hypertension in high-volume claims data"],"prefix":"10.1016","volume":"109","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-1388-7029","authenticated-orcid":false,"given":"Sori Kim","family":"Lundin","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xinyue","family":"Hu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jingna","family":"Feng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Karl Kristian","family":"Lundin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lu","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yong","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Paul Ernest","family":"Schulz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4267-1924","authenticated-orcid":false,"given":"Cui","family":"Tao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.ebiom.2024.105378_bib2","doi-asserted-by":"crossref","first-page":"1269","DOI":"10.1161\/HYP.0000000000000066","volume":"71","author":"Whelton","year":"2018","journal-title":"Hypertension"},{"key":"10.1016\/j.ebiom.2024.105378_bib3","doi-asserted-by":"crossref","first-page":"1598","DOI":"10.1002\/alz.13016","article-title":"2023 Alzheimer\u2019s disease facts and figures","volume":"19","year":"2023","journal-title":"Alzheimers Dement"},{"key":"10.1016\/j.ebiom.2024.105378_bib4","doi-asserted-by":"crossref","first-page":"1246","DOI":"10.1001\/jamaneurol.2017.1658","article-title":"Associations between midlife vascular risk factors and 25-year incident dementia in the atherosclerosis risk in communities (ARIC) cohort","volume":"74","author":"Gottesman","year":"2017","journal-title":"JAMA Neurol"},{"key":"10.1016\/j.ebiom.2024.105378_bib5","doi-asserted-by":"crossref","first-page":"460","DOI":"10.1159\/000330020","article-title":"Vascular risk factors and dementia: 40-year follow-up of a population-based cohort","volume":"31","author":"R\u00f6nnemaa","year":"2011","journal-title":"Dement Geriatr Cogn Disord"},{"key":"10.1016\/j.ebiom.2024.105378_bib6","doi-asserted-by":"crossref","first-page":"e67","DOI":"10.1161\/HYP.0000000000000053","article-title":"Impact of hypertension on cognitive function: a scientific statement from the American heart association","volume":"68","author":"Iadecola","year":"2016","journal-title":"Hypertension"},{"key":"10.1016\/j.ebiom.2024.105378_bib7","doi-asserted-by":"crossref","first-page":"413","DOI":"10.1016\/S0140-6736(20)30367-6","article-title":"Dementia prevention, intervention, and care: 2020 report of the Lancet Commission","volume":"396","author":"Livingston","year":"2020","journal-title":"Lancet"},{"key":"10.1016\/j.ebiom.2024.105378_bib8","doi-asserted-by":"crossref","first-page":"680","DOI":"10.15585\/mmwr.mm7120a2","article-title":"Modifiable risk factors for alzheimer disease and related dementias among adults aged \u226545 Years - United States, 2019","volume":"71","author":"Omura","year":"2022","journal-title":"MMWR Morb Mortal Wkly Rep"},{"key":"10.1016\/j.ebiom.2024.105378_bib9","series-title":"Preventing cognitive decline and dementia: a way forward","article-title":"National Academies of Sciences, Engineering, and Medicine, Health and Medicine Division, board on health sciences policy, committee on preventing dementia and cognitive impairment","year":"2017"},{"key":"10.1016\/j.ebiom.2024.105378_bib10","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1016\/S1474-4422(19)30393-X","article-title":"Antihypertensive medications and risk for incident dementia and Alzheimer\u2019s disease: a meta-analysis of individual participant data from prospective cohort studies","volume":"19","author":"Ding","year":"2020","journal-title":"Lancet Neurol"},{"key":"10.1016\/j.ebiom.2024.105378_bib11","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1007\/s40263-015-0230-6","article-title":"Antihypertensive drugs, prevention of cognitive decline and dementia: a systematic review of observational studies, randomized controlled trials and meta-analyses, with discussion of potential mechanisms","volume":"29","author":"Rouch","year":"2015","journal-title":"CNS Drugs"},{"key":"10.1016\/j.ebiom.2024.105378_bib12","doi-asserted-by":"crossref","first-page":"1073","DOI":"10.1097\/HJH.0b013e3283603f53","article-title":"Antihypertensive classes, cognitive decline and incidence of dementia: a network meta-analysis","volume":"31","author":"Levi","year":"2013","journal-title":"J\u00a0Hypertens"},{"key":"10.1016\/j.ebiom.2024.105378_bib13","doi-asserted-by":"crossref","first-page":"e267","DOI":"10.1212\/WNL.0000000000008732","article-title":"Investigation of antihypertensive class, dementia, and cognitive decline: a meta-analysis","volume":"94","author":"Peters","year":"2020","journal-title":"Neurology"},{"key":"10.1016\/j.ebiom.2024.105378_bib14","doi-asserted-by":"crossref","first-page":"888","DOI":"10.1212\/WNL.0b013e3182a351d4","article-title":"Antihypertensive medication use and risk of cognitive impairment: the Honolulu-Asia Aging Study","volume":"81","author":"Gelber","year":"2013","journal-title":"Neurology"},{"key":"10.1016\/j.ebiom.2024.105378_bib15","doi-asserted-by":"crossref","DOI":"10.1155\/2017\/4368474","article-title":"Association between antihypertensive drug use and the incidence of cognitive decline and dementia: a meta-analysis of prospective cohort studies","volume":"2017","author":"Xu","year":"2017","journal-title":"BioMed Res Int"},{"key":"10.1016\/j.ebiom.2024.105378_bib16","doi-asserted-by":"crossref","first-page":"553","DOI":"10.1001\/jama.2018.21442","article-title":"Effect of intensive vs standard blood pressure control on probable dementia: a randomized clinical trial","volume":"321","author":"SPRINT MIND Investigators for the SPRINT Research Group","year":"2019","journal-title":"JAMA"},{"key":"10.1016\/j.ebiom.2024.105378_bib17","doi-asserted-by":"crossref","first-page":"683","DOI":"10.1016\/S1474-4422(08)70143-1","article-title":"Incident dementia and blood pressure lowering in the Hypertension in the Very Elderly Trial cognitive function assessment (HYVET-COG): a double-blind, placebo controlled trial","volume":"7","author":"Peters","year":"2008","journal-title":"Lancet Neurol"},{"issue":"10046","key":"10.1016\/j.ebiom.2024.105378_bib18","doi-asserted-by":"crossref","first-page":"797","DOI":"10.1016\/S0140-6736(16)30950-3","article-title":"Effectiveness of a 6-year multidomain vascular care intervention to prevent dementia (preDIVA): a cluster-randomised controlled trial","volume":"388","author":"Moll van Charante","year":"2016","journal-title":"Lancet"},{"key":"10.1016\/j.ebiom.2024.105378_bib19","first-page":"123","article-title":"Angiotensin II receptor blockers","volume":"16","author":"Barreras","year":"2003","journal-title":"SAVE Proc"},{"key":"10.1016\/j.ebiom.2024.105378_bib20","doi-asserted-by":"crossref","first-page":"1334","DOI":"10.1161\/HYPERTENSIONAHA.120.15026","article-title":"2020 International society of hypertension global hypertension practice guidelines","volume":"75","author":"Unger","year":"2020","journal-title":"Hypertension"},{"key":"10.1016\/j.ebiom.2024.105378_bib21","doi-asserted-by":"crossref","DOI":"10.1016\/j.phrs.2021.105515","article-title":"Association between renin-angiotensin-aldosterone system inhibitors and risk of dementia: a meta-analysis","volume":"166","author":"Scotti","year":"2021","journal-title":"Pharmacol Res"},{"key":"10.1016\/j.ebiom.2024.105378_bib22","doi-asserted-by":"crossref","first-page":"938","DOI":"10.1097\/HJH.0000000000000086","article-title":"Angiotension receptor blockers reduce the risk of dementia","volume":"32","author":"Chiu","year":"2014","journal-title":"J\u00a0Hypertens"},{"key":"10.1016\/j.ebiom.2024.105378_bib23","doi-asserted-by":"crossref","first-page":"1345","DOI":"10.1161\/HYPERTENSIONAHA.109.138586","article-title":"Angiotensin receptor blocker prevented beta-amyloid-induced cognitive impairment associated with recovery of neurovascular coupling","volume":"54","author":"Takeda","year":"2009","journal-title":"Hypertension"},{"key":"10.1016\/j.ebiom.2024.105378_bib24","doi-asserted-by":"crossref","first-page":"373","DOI":"10.1016\/S1474-4422(07)70077-7","article-title":"Is inhibition of the renin-angiotensin system a new treatment option for Alzheimer\u2019s disease?","volume":"6","author":"Kehoe","year":"2007","journal-title":"Lancet Neurol"},{"key":"10.1016\/j.ebiom.2024.105378_bib25","doi-asserted-by":"crossref","DOI":"10.1136\/bmj.b5465","article-title":"Use of angiotensin receptor blockers and risk of dementia in a predominantly male population: prospective cohort analysis","volume":"340","author":"Li","year":"2010","journal-title":"BMJ"},{"issue":"10","key":"10.1016\/j.ebiom.2024.105378_bib26","doi-asserted-by":"crossref","first-page":"2159","DOI":"10.1161\/HYPERTENSIONAHA.122.19378","article-title":"Angiotensin receptor blockers are associated with a lower risk of progression from mild cognitive impairment to dementia","volume":"79","author":"Deng","year":"2022","journal-title":"Hypertension"},{"key":"10.1016\/j.ebiom.2024.105378_bib27","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1016\/S1474-4422(10)70250-7","article-title":"Renin-angiotensin system blockade and cognitive function in patients at high risk of cardiovascular disease: analysis of data from the ONTARGET and TRANSCEND studies","volume":"10","author":"Anderson","year":"2011","journal-title":"Lancet Neurol"},{"key":"10.1016\/j.ebiom.2024.105378_bib28","doi-asserted-by":"crossref","first-page":"629","DOI":"10.1161\/HYPERTENSIONAHA.121.17049","article-title":"Blood-brain barrier crossing renin-angiotensin drugs and cognition in the elderly: a meta-analysis","volume":"78","author":"Ho","year":"2021","journal-title":"Hypertension"},{"key":"10.1016\/j.ebiom.2024.105378_bib29","article-title":"Angiotensin converting enzyme (ACE) inhibitors versus angiotensin receptor blockers for primary hypertension","volume":"2014","author":"Li","year":"2014","journal-title":"Cochrane Database Syst Rev"},{"key":"10.1016\/j.ebiom.2024.105378_bib30","doi-asserted-by":"crossref","first-page":"188","DOI":"10.1016\/j.jamda.2018.08.002","article-title":"Exploiting drug-apolipoprotein E gene interactions in hypertension to preserve cognitive function: the 3-city cohort study","volume":"20","author":"Tully","year":"2019","journal-title":"J\u00a0Am Med Dir Assoc"},{"key":"10.1016\/j.ebiom.2024.105378_bib31","doi-asserted-by":"crossref","first-page":"779","DOI":"10.3233\/JAD-150487","article-title":"Alzheimer\u2019s disease neuroimaging initiative. Older adults taking AT1-receptor blockers exhibit reduced cerebral amyloid retention","volume":"50","author":"Nation","year":"2016","journal-title":"J\u00a0Alzheimers Dis"},{"key":"10.1016\/j.ebiom.2024.105378_bib32","series-title":"Basic tabulation list with alphabetical index","year":"1978"},{"key":"10.1016\/j.ebiom.2024.105378_bib35","doi-asserted-by":"crossref","first-page":"420","DOI":"10.1002\/gps.5030","article-title":"Using electronic health records to estimate the prevalence of agitation in Alzheimer disease\/dementia","volume":"34","author":"Halpern","year":"2019","journal-title":"Int J Geriatr Psychiatry"},{"key":"10.1016\/j.ebiom.2024.105378_bib36","doi-asserted-by":"crossref","first-page":"1061","DOI":"10.3233\/JAD-220361","article-title":"Risk of Alzheimer\u2019s disease following influenza vaccination: a claims-based cohort study using propensity score matching","volume":"88","author":"Bukhbinder","year":"2022","journal-title":"J\u00a0Alzheimers Dis"},{"key":"10.1016\/j.ebiom.2024.105378_bib37","doi-asserted-by":"crossref","first-page":"211","DOI":"10.1007\/s10654-019-00494-6","article-title":"Principles of confounder selection","volume":"34","author":"VanderWeele","year":"2019","journal-title":"Eur J Epidemiol"},{"key":"10.1016\/j.ebiom.2024.105378_bib38","doi-asserted-by":"crossref","first-page":"268","DOI":"10.7326\/M16-2607","article-title":"Sensitivity analysis in observational research: introducing the E-value","volume":"167","author":"VanderWeele","year":"2017","journal-title":"Ann Intern Med"},{"key":"10.1016\/j.ebiom.2024.105378_bib39","doi-asserted-by":"crossref","first-page":"2009","DOI":"10.1056\/NEJMoa1600175","article-title":"Blood-pressure lowering in intermediate-risk persons without cardiovascular disease","volume":"374","author":"Lonn","year":"2016","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.ebiom.2024.105378_bib40","doi-asserted-by":"crossref","first-page":"1707","DOI":"10.1002\/sim.4780141510","article-title":"Graphical methods for assessing violations of the proportional hazards assumption in Cox regression","volume":"14","author":"Hess","year":"1995","journal-title":"Stat Med"},{"key":"10.1016\/j.ebiom.2024.105378_bib41","doi-asserted-by":"crossref","first-page":"239","DOI":"10.1093\/biomet\/69.1.239","article-title":"Partial residuals for the proportional hazards regression model","volume":"69","author":"Schoenfeld","year":"1982","journal-title":"Biometrika"},{"key":"10.1016\/j.ebiom.2024.105378_bib42","doi-asserted-by":"crossref","first-page":"507","DOI":"10.1001\/jama.2013.284427","article-title":"2014 evidence-based guideline for the management of high blood pressure in adults: report from the panel members appointed to the Eighth Joint National Committee (JNC 8)","volume":"311","author":"James","year":"2014","journal-title":"JAMA"},{"key":"10.1016\/j.ebiom.2024.105378_bib43","author":"Asenjo"},{"key":"10.1016\/j.ebiom.2024.105378_bib44","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0206705","article-title":"The association of multiple anti-hypertensive medication classes with Alzheimer\u2019s disease incidence across sex, race, and ethnicity","volume":"13","author":"Barthold","year":"2018","journal-title":"PLoS One"},{"key":"10.1016\/j.ebiom.2024.105378_bib45","doi-asserted-by":"crossref","first-page":"37644","DOI":"10.1074\/jbc.M508460200","article-title":"Amyloid \u03b2-protein is degraded by cellular angiotensin-converting enzyme (ACE) and elevated by an ACE inhibitor","volume":"280","author":"Hemming","year":"2005","journal-title":"J\u00a0Biol Chem"},{"key":"10.1016\/j.ebiom.2024.105378_bib46","doi-asserted-by":"crossref","first-page":"8628","DOI":"10.1523\/JNEUROSCI.1549-07.2007","article-title":"Angiotensin-converting enzyme converts amyloid beta-protein 1-42 (Abeta(1-42)) to Abeta(1-40), and its inhibition enhances brain Abeta deposition","volume":"27","author":"Zou","year":"2007","journal-title":"J\u00a0Neurosci"},{"key":"10.1016\/j.ebiom.2024.105378_bib47","doi-asserted-by":"crossref","first-page":"221","DOI":"10.3389\/fphar.2015.00221","article-title":"\u03b2-Amyloid: the key peptide in the pathogenesis of Alzheimer\u2019s disease","volume":"6","author":"Sun","year":"2015","journal-title":"Front Pharmacol"},{"key":"10.1016\/j.ebiom.2024.105378_bib48","doi-asserted-by":"crossref","first-page":"1698","DOI":"10.1016\/S0140-6736(15)00463-8","article-title":"Vascular dementia","volume":"386","author":"O\u2019Brien","year":"2015","journal-title":"Lancet"},{"key":"10.1016\/j.ebiom.2024.105378_bib49","doi-asserted-by":"crossref","first-page":"644","DOI":"10.1161\/HYPERTENSIONAHA.121.17595","article-title":"Blood-brain barrier crossing renin-angiotensin system drugs: considerations for dementia and cognitive decline","volume":"78","author":"Glodzik","year":"2021","journal-title":"Hypertension"},{"key":"10.1016\/j.ebiom.2024.105378_bib50","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1186\/s13195-017-0255-9","article-title":"Alzheimer\u2019s Disease Neuroimaging Initiative. Memory is preserved in older adults taking AT1 receptor blockers","volume":"9","author":"Ho","year":"2017","journal-title":"Alzheimers Res Ther"},{"key":"10.1016\/j.ebiom.2024.105378_bib51","doi-asserted-by":"crossref","first-page":"214","DOI":"10.1001\/archneurol.2010.362","article-title":"Hearing loss and incident dementia","volume":"68","author":"Lin","year":"2011","journal-title":"Arch Neurol"},{"key":"10.1016\/j.ebiom.2024.105378_bib52","doi-asserted-by":"crossref","first-page":"7556","DOI":"10.1038\/s41598-023-33701-2","article-title":"Treatment of hypertension and obstructive sleep apnea counteracts cognitive decline in common neurocognitive disorders in diagnosis-related patterns","volume":"13","author":"Kujovic","year":"2023","journal-title":"Sci Rep"},{"key":"10.1016\/j.ebiom.2024.105378_bib53","doi-asserted-by":"crossref","first-page":"194","DOI":"10.1097\/EDE.0000000000001312","article-title":"To adjust or not to adjust? When a \u201cconfounder\u201d is only measured after exposure","volume":"32","author":"Groenwold","year":"2021","journal-title":"Epidemiology"},{"key":"10.1016\/j.ebiom.2024.105378_bib54","doi-asserted-by":"crossref","first-page":"361","DOI":"10.1007\/s12170-010-0118-4","article-title":"Apolipoprotein E genotype and cardiovascular diseases in the elderly","volume":"4","author":"Haan","year":"2010","journal-title":"Curr Cardiovasc Risk Rep"}],"container-title":["eBioMedicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2352396424004146?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2352396424004146?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2024,11,19]],"date-time":"2024-11-19T19:38:19Z","timestamp":1732045099000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2352396424004146"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,11]]},"references-count":51,"alternative-id":["S2352396424004146"],"URL":"https:\/\/doi.org\/10.1016\/j.ebiom.2024.105378","relation":{},"ISSN":["2352-3964"],"issn-type":[{"value":"2352-3964","type":"print"}],"subject":[],"published":{"date-parts":[[2024,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Association between risk of Alzheimer\u2019s disease and related dementias and angiotensin receptor \u2161 blockers treatment for individuals with hypertension in high-volume claims data","name":"articletitle","label":"Article Title"},{"value":"eBioMedicine","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ebiom.2024.105378","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 The Authors. Published by Elsevier B.V.","name":"copyright","label":"Copyright"}],"article-number":"105378"}}